THC

Tenet Healthcare Corp. 10-Q Summary (Period Ended June 30, 2004)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2004, for Tenet Healthcare Corporation, a provider of acute care hospital services. The company is in a significant restructuring phase, having announced plans to divest 27 domestic general hospitals to focus on a core portfolio of 69 facilities. The reporting period includes the reclassification of certain operations as "discontinued" to reflect these divestitures.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net operating revenues from continuing operations decreased 3.1% year-over-year, driven by lower patient volumes (admissions down 1.2%) and the phasing in of price discounts for uninsured patients under the "Compact" program.
• Profitability Deterioration: The company swung from an operating profit of $101 million in the prior year to an operating loss of $202 million. This was primarily due to a massive increase in the provision for doubtful accounts ($328 million increase) and higher malpractice expenses.
• Discontinued Operations: Significant losses were recorded in discontinued operations ($318 million loss for six months) due to impairment charges ($334 million) related to hospitals slated for divestiture, partially offset by gains on asset sales.
• Liquidity Improvement: Despite the operating loss, cash on hand increased significantly from $221 million to $1,193 million. This was driven by the issuance of $1 billion in new Senior Notes and proceeds from asset sales ($190 million), offsetting the decline in operating cash flow.

Guidance, Outlook, and Risks

Management Commentary: Management does not anticipate significant operating performance or margin improvement in 2004 or potentially 2005. The company is focused on cost reduction, streamlining operations, and resolving legal matters. The "Compact" program for uninsured patients is expected to reduce future bad debt provisions but currently reduces reported net revenues.

Outlook: The company expects to complete the divestiture of 27 hospitals by the end of 2004. Long-term prospects are viewed positively for the remaining 69 hospitals, though short-term results will be impacted by restructuring costs and the time required to implement efficiency initiatives.

Risks and Contingencies:

• Legal and Regulatory: The company faces extensive federal and state investigations regarding physician relationships, Medicare outlier payments, and pricing strategies. A potential non-litigated resolution with the federal government could require significant debt financing.
• Redding Medical Center: Significant civil litigation remains regarding alleged medically unnecessary cardiac procedures, with approximately 700-800 patient cases anticipated.
• IRS Examination: The IRS has proposed a tax deficiency of $157 million plus interest for fiscal years 1995-1997; the company has filed a protest.
• Insurance Reserves: Professional liability reserves are approximately $719 million. If policy aggregates are exhausted, the company could face material adverse effects.

Investor Verification Checklist

• Bad Debt Methodology: Verify the impact of the changed estimation process for self-pay accounts on future revenue recognition and bad debt provisions.
• Divestiture Timeline: Confirm the completion dates and final proceeds for the 27 announced hospital divestitures, particularly the four Los Angeles hospitals and the Medical College of Pennsylvania Hospital.
• Legal Exposure: Monitor the status of the federal investigations and the potential financial impact of a non-litigated settlement with the government.
• Debt Covenants: Review compliance with the amended credit agreement covenants (leverage ratio and fixed-charge coverage) given the current operating losses.
• Compact Implementation: Assess the progress of the "Compact" discount program in Texas and California, where legal issues may limit implementation.